Primary Category:
Treatment Protocols
Disease Category:
Endometrial, Gynecologic, Ovarian
Status:
Closed
A Phase II Study of Tazemetostat (EPZ-6438) (IND # 138671) in Recurrent or Persistent Endometrioid or Clear Cell Carcinoma of the Ovary, and Recurrent or Persistent Endometrioid Endometrial Adenocarcinoma
NCT#03348631